T. Rowe Price Health Sciences Fund

Class No Load (PRHSX)
Scorecard
5 / 5 Stars
Lipper
5 5 4 5 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
B+ (Buy)

Fund Performance

The fund's Value Line Growth Persistence rank, which awards funds that consistently outperform their broad universes, is 2 for one year, 1 for five years, and 1 for 10 years. Scores are on a 1 to 5 scale, with 1 being the best and 5 the worst.

Value Line 2014-06-11

Hypothetical Growth of $10,000

Updated 06.30.2014

Trailing Total Returns

Updated 06.30.2014

Total Return % + / - MSCI ACWI NR USD + / - S&P 1500 Health Care TR % Rank
Year-to-date 10.64 4.46 0.44 62
1-Month 3.41 1.53 1.12 79
3-Month 4.39 -0.65 -0.18 63
6-Month 10.64 4.46 0.44 62
1-Year 40.45 17.50 10.53 18
3-Year (Annualized) 27.47 17.22 5.45 20
5-Year (Annualized) 27.98 13.70 6.82 2
10-Year (Annualized) 15.26 7.79 5.65 6